Overview
Blautia obeum is a strictly anaerobic, Gram-positive bacterium belonging to the family Lachnospiraceae within the phylum Firmicutes. It is a common member of the healthy human gut microbiome, recognized primarily for its role in colonization resistance against enteric pathogens and its involvement in bile acid and cholesterol metabolism. Research suggests that B. obeum may serve as an important protective component of the gut ecosystem, with its presence associated with reduced susceptibility to infections and improved outcomes in hematopoietic stem cell transplant recipients.
Classification
B. obeum belongs to the genus Blautia, which was established after phylogenetic reclassification of several species formerly assigned to Ruminococcus and other genera. It is closely related to Blautia wexlerae and Blautia producta within the Lachnospiraceae family. The genus Blautia encompasses obligate anaerobes that are among the most abundant organisms in the human gut microbiome, collectively playing important roles in carbohydrate fermentation and immune modulation.
Key Characteristics
B. obeum demonstrates significant antimicrobial capabilities, showing the ability to inhibit the proliferation of Clostridium perfringens and vancomycin-resistant enterococci (VRE) in vitro, potentially through bacteriocin production or metabolic competition. It has also been identified as a key species providing colonization resistance against Vibrio cholerae, with its abundance showing a significant negative correlation with cholera pathogen colonization in patient gut microbiome analyses. Additionally, B. obeum participates in cholesterol and bile acid metabolism, which may contribute to its broader metabolic effects in the gut ecosystem.
Health Significance
The clinical significance of B. obeum extends beyond the gastrointestinal tract. In a landmark study published in the New England Journal of Medicine, increased Blautia diversity (including B. obeum) in the gut microbiome of allogeneic bone marrow transplant patients was significantly associated with reduced lethal graft-versus-host disease (GVHD) and improved overall survival. This finding suggests that B. obeum may play a role in immune homeostasis beyond simple pathogen resistance. However, some studies have noted elevated B. obeum levels in certain IBS and ulcerative colitis patients, indicating that its effects may be context-dependent. Overall, B. obeum appears to be a protective commensal under typical gut conditions, though more research is needed to fully delineate when its abundance may become clinically relevant.